Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

NeurAxon Announces Closing of Convertible Debenture Financing
WALTHAM, MA. December 29, 2009 - NeurAxon, Inc., a development-stage pharmaceutical company that is designing and developing next-generation pain therapeutics... Read more
Inverness Medical Innovations Enters Into Distribution Agreement with Epocal Inc.
WALTHAM, Mass., Jan. 5 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take... Read more